Gestational trophoblastic disease | |
---|---|
Micrograph of intermediate trophoblast, decidua and a hydatidiform mole (bottom of image). H&E stain. | |
Specialty | Oncology |
Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours.[1] These tumours are rare, and they appear when cells in the womb start to proliferate uncontrollably. The cells that form gestational trophoblastic tumours are called trophoblasts and come from tissue that grows to form the placenta during pregnancy.
There are several different types of GTD. A hydatidiform mole also known as a molar pregnancy, is the most common and is usually benign. Sometimes it may develop into an invasive mole, or, more rarely into a choriocarcinoma. A choriocarcinoma is likely to spread quickly,[2][3] but is very sensitive to chemotherapy, and has a very good prognosis. Trophoblasts are of particular interest to cell biologists because, like cancer, they can invade tissue (the uterus), but unlike cancer, they usually "know" when to stop.[citation needed]
GTD can simulate pregnancy, because the uterus may contain fetal tissue, albeit abnormal. This tissue may grow at the same rate as a normal pregnancy, and produces chorionic gonadotropin, a hormone which is measured to monitor fetal well-being.[4]
While GTD overwhelmingly affects women of child-bearing age, it may rarely occur in postmenopausal women.[5]